Skip to main content
. 2022 Jul 28;13:968729. doi: 10.3389/fimmu.2022.968729

Figure 7.

Figure 7

In different ATB window, the subgroup analysis between ATB use and PFS of cancer patients treated with ICIs. (A) ATB window (-30 days, 30 day); (B) ATB window (-60 days, 0 days); (C) ATB window (-60 days, 30 days); (D) ATB window (0 days, 30 days).